Celldex Therapeutics, Inc.

Contributing Author

Recent Articles by Celldex Therapeutics, Inc.

May-08	Celldex Reports First Quarter 2025 Financial Results and Provides Corporate Update CLDX GlobeNewswire
May-05	Celldex Presents Histology Data from Phase 2 Study of Barzolvolimab in EoE Supporting Potential of Mast Depleting Agent in this Difficult to Treat Disease CLDX GlobeNewswire